Dr. Bishop is an associate Professor in the Department of Psychiatry and Behavioral Sciences and Weill Institute for Neurosciences at UCSF. She is a clinical psychologist with expertise in assessment, diagnosis, and treatment of individuals with autism spectrum disorders. Her research and clinical interests are focused on ASD symptom manifestations in individuals of different ages and levels of ability, as well as on differentiating between ASD and other developmental disabilities across the lifespan.
Dr. Wu is a magnetic resonance imaging physicist by training. Her research focuses on diffusion physics in biologic system using diffusion MRI. She started to work on diffusion MRI extensively in her graduate education. She continued to advance in this field independently at Dartmouth College (2009-2013) and currently at Indiana University School of Medicine.
Most infants and toddlers have a prodigious ability to learn, in part because they spend a lot of time interacting with caregivers. In the Princeton Baby Lab, we study how the mechanisms of infant cognition and the details of environmental experience combine to shape early learning. In particular, we study the beginnings of language learning and communication.
Julie Lounds Taylor, Ph.D. is the Transitions Lab Principal Investigator (PI) and lab director. She is an associate professor of pediatrics at Vanderbilt University Medical Center, and an investigator at the Vanderbilt Kennedy Center for Research on Human Development. A major focus of Taylor’s research is on factors that promote a positive transition into adulthood for individuals with developmental disabilities, in particular those with autism spectrum disorder.
Peter K. Todd, M.D., Ph.D., is the Bucky and Patti Harris Professor and Associate Chair of research in the Department of Neurology in the University of Michigan Medical School. Todd’s lab studies the mechanisms by which nucleotide repeat expansions cause neurological disorders with a long term goal of developing novel therapeutics for these currently untreatable conditions.
Anna Esbensen, PhD, is an associate professor of pediatrics at the University of Cincinnati College of Medicine in the Division of Developmental and Behavioral Pediatrics at Cincinnati Children’s Hospital Medical Center. She studies the lifespan development of individuals with Down syndrome and provides clinical services to families of children with Down syndrome.
Dr. Maddox is an assistant Professor in the department of psychiatry. As the implementation scientist at TEACCH, her work focuses on improving community services for people on the autism spectrum across the lifespan.
Dr. Peng is a member of both the Structural Biology and Developmental Neurobiology departments at St. Jude and serves as the director of the Center for Proteomics and Metabolomics. His research involves using mass spectrometry-based proteomics, metabolomics and systems biology to understand mechanisms of human disease.
Dr. Stephen Scherer’s research includes understanding the composition of the human genome for studies of genetic disease built around three themes: 1) gene copy number and structural variation in the human genome, 2) determining the genetic architecture in autism spectrum and related- disorders and using this information to help families, and 3) developing infrastructure and capacity in Canada for translational genomics research.
Dr. Carlos Portera-Cailliau investigates synaptic and circuit changes in the mouse model of Fragile X syndrome in his lab at the UCLA David Geffen School of Medicine, where he is on faculty. He has received grants from the NIH, the Dana Foundation, the March of Dimes Foundation, the Simons Foundation, and the John Merck Fund. From 2013 to 2021 he was the co-director of the UCLA-Caltech medical Scientist Training Program. He still sees patients in the movement disorders clinic.